MedTrace Logo

Safety and Efficacy of Intrapulmonary Percussive Ventilation in Preterm Infants

NCT06229821 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2024-01-31

No results posted yet for this study

Summary

The purpose of this study is to evaluate the benefits and safety of Intrapulmonary Percussive Ventilation in preterm infants. IPV has been demonstrated to be safe, and improve airway secretions clearance and decreased atelectasis in pediatric patients. We aim to evaluate the effects of IPV in preterm infants.

Conditions

  • Respiratory Distress Syndrome in Premature Infant

Interventions

DEVICE

Intrapulmonary Percussive Ventilation

IPV applied at increasing intervals, starting every 6 hours, and ending at every 24 hours, for a total of 7 days.

Sponsors & Collaborators

  • Augusta University

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
14 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-01
Primary Completion
2024-12-31
Completion
2024-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06229821 on ClinicalTrials.gov